Rapid Fire Session
Shahnaz Akil, MSc
Technologist, PhD
Lund university and Skåne University Hospital, Lund
Lund, Skane Lan, Sweden
Shahnaz Akil, MSc
Technologist, PhD
Lund university and Skåne University Hospital, Lund
Lund, Skane Lan, Sweden
Morten Kraen, MD, PhD
Senior consultant, PhD
Skåne University Hospital, Lund, Sweden
Barbro Kjellström, PhD
PhD
Lund University and Skåne University Hospital, Lund, Sweden, Sweden
Ellen Ostenfeld, MD, PhD
MD, PhD, Associate professor
Lund University and Skåne University Hospital, Lund, Sweden
Lund, Skane Lan, Sweden
Peter Kellman, PhD
Director
National Heart, Lung, and Blood Institute, National Institutes of Health, United States
Håkan Arheden, MD, PhD
MD, PhD, Professor
Lund University and Skåne University Hospital, Lund, Sweden
Lund, Sweden
Henrik Engblom, MD, PhD
Professor, MD
Clinical Physiology, Department of Clinical Sciences Lund, Lund University, Skåne University Hospital, Lund, Sweden
Lund, Skane Lan, Sweden
| Females (n=764) | Males (n=736) | P-value |
Age (years±SD) | 65±13 | 62±13 | < 0.001 |
Diabetes | 56 (7%) | 62 (8%) | 0.43 |
Hypertension | 185 (24%) | 189 (26%) | 0.51 |
Prior ischemic heart disease | 66 (9%) | 94 (13%) | 0.01 |
Follow-up data: | |||
Follow-up time (years±SD) | 2.7±0.8 | 2.6±0.9 | 0.01 |
MACE | 22 (3%) | 47 (6%) | 0.002 |
Invasive angiography | 47 (6%) | 79 (11%) | 0.002 |
Figure 2. Proportion of patients without subsequent revascularization (PCI or CABG) following invasive coronary angiography during the 5-year follow-up. Note that the proportion of females (68%) was significantly higher than in males (42%). 